AVITA Medical RCEL
NASDAQ RCEL
$10.20 -0.14 (-1.31%)
At close: Aug 20, 2026 · 1:21 PM UTC

AVITA Medical (RCEL) Net Cash Flow Growth (5y) (2024 - 2025)

AVITA Medical (RCEL) Net Cash Flow Growth (5y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn
10 AVITA Medical 313.80 Mn 302.67 Mn 17.77 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.96%
Sep 30, 2025 19.14%
Mar 31, 2025 16.08%
Dec 31, 2024 -15.59%
Sep 30, 2024 17.45%